The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Treatment of ADHD in children with tics: A randomized controlled trial
Abstract
BACKGROUND: The treatment of children with attention deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) has been problematic because methylphenidate (MPH)--the most commonly used drug to treat ADHD--has been reported to worsen tics and because clonidine (CLON)--the most commonly prescribed alternative--has unproven efficacy. METHODS: The authors conducted a multicenter, randomized, double-blind clinical trial in which 136 children with ADHD and a chronic tic disorder were randomly administered CLON alone, MPH alone, combined CLON + MPH, or placebo (2 x 2 factorial design). Each subject participated for 16 weeks (weeks 1-4 CLON/placebo dose titration, weeks 5-8 added MPH/placebo dose titration, weeks 9-16 maintenance therapy). RESULTS: Thirty-seven children were administered MPH alone, 34 were administered CLON alone, 33 were administered CLON + MPH, and 32 were administered placebo. For our primary outcome measure of ADHD (Conners Abbreviated Symptom Questionnaire--Teacher), significant improvement occurred for subjects assigned to CLON (p < 0.002) and those assigned to MPH (p < 0.003). Compared with placebo, the greatest benefit occurred with combined CLON + MPH (p < 0.0001). CLON appeared to be most helpful for impulsivity and hyperactivity; MPH appeared to be most helpful for inattention. The proportion of individual subjects reporting a worsening of tics as an adverse effect was no higher in those treated with MPH (20%) than those being administered CLON alone (26%) or placebo (22%). Compared with placebo, measured tic severity lessened in all active treatment groups in the following order: CLON + MPH, CLON alone, MPH alone. Sedation was common with CLON treatment (28% reported moderate or severe sedation), but otherwise the drugs were tolerated well, including absence of any evident cardiac toxicity. CONCLUSIONS: Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics. Prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For clonidine, which is only occasionally used in Europe to treat TD and/or ADHD, but recommended by some authors (especially where TD is the predominant disorder) [116], there exists some evidence that it may reduce tics in frequency and severity, as well as improve ADHD symptoms; but on the other hand, worsening of tics may be seen in about a quarter of cases [3].”
From European guidelines on managing adverse effects of medication for ADHD (2011) · cites this paper as [3]
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
Normative data on Revised Conners Parent and Teacher Rating Scales
Goyette, C. H., Conners, C. K., & Ulrich, R. F. (1978) · Research on Child and Adolescent Psychopathology · doi:10.1007/bf00919127 · Cited by 1,728
Teacher Ratings of DSM-III-R Symptoms for the Disruptive Behavior Disorders
Pelham, W. E., Gnagy, E. M., Greenslade, K. E., & Milich, R. S. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199203000-00006 · Cited by 1,315
Scahill, L., Chappell, P. B., Kim, Y. S., Schultz, R. T., Katsovich, L., Shepherd, E., Arnsten, A. F. T., Cohen, D. J., & Leckman, J. F. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.7.1067 · Cited by 588
Clonidine Treatment of Gilles de la Tourette's Syndrome
Leckman, J. F. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280040006 · Cited by 334
An Open Trial of Guanfacine in the Treatment of Attention-Deficit Hyperactivity Disorder
Hunt, R. D., Arnsten, A. F. T., & Asbell, M. D. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199501000-00013 · Cited by 308
Effect of Stimulant Medication on Children with Attention Deficit Disorder: A “Review of Reviews”
Swanson, J. M., McBurnett, K., Wigal, T. L., Pfiffner, L. J., Lerner, M., Williams, L., Christian, D. L., Tamm, L., Willcutt, E. G., Crowley, K., et al. (1993) · Exceptional Children · doi:10.1177/001440299306000209 · Cited by 305
Stimulant Medications Precipitate Tourette's Syndrome
Lowe, T. L. (1982) · JAMA · doi:10.1001/jama.1982.03320370043028 · Cited by 256
Fisher, P. W., Shaffer, D. R., Piacentini, J. C., Lapkin, J. B., Kafantaris, V., Leonard, H., & Herzog, D. B. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199305000-00026 · Cited by 251
Research works printed but not linked: 7
- Walkup JT Khan S Schuerholz L et al. Phenomenology and natural history of tic-related ADHD and learning disabilities. In: Leckman JF Cohen DJ eds. Tourette’s syndrome: tics obsessions compulsions. New York: Wiley 1999; 63–79.
- Kurlan R Trinidad KS. Treatment of tics. In: Kurlan R ed. The Treatment of Movement Disorders. Philadelphia: JB Lippincott 1995; 365–406.
- Tanner JM. Growth in adolescence 2nd ed. Oxford: Blackwell Scientific 1962.
- Atkins MS Pelham WE Licht MH. The development and validation of objective classroom measures for conduct and attention deficit disorders. In: Prinz R ed. Advances in behavioral assessment of children and families Vol 4. Greenwich CT: JAI Press 1988; 3–33.
- Leckman JF Towbin KE Ort SI Cohen DJ. Clinical assessment of tic disorder severity. In: Cohen DJ Bruun RD Leckman JF eds. Tourette’s syndrome and tic disorders. New York: Wiley 1988: 55–78.
- Scahill L King RA Schultz RT Leckman JF. Selection and use of diagnostic and clinical rating instruments. In: Leckman JF Cohen DJ eds. Tourette’s syndrome tics obsessions compulsions: development psychopathology and clinical care. New York: John Wiley and Sons 1998; 310–324.
- Conners CK, Barkley RA. Rating scales and checklists for psychopharmacologic trials. Psychopharm Bull . 1985; 21: 809–854.
Cited by
Sorted by citations
Items 201–300 of 507
Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder
Handen, B. L., Taylor, J., & Tumuluru, R. (2011) · ijamh · doi:10.1515/ijamh.2011.039 · Cited by 26
An open-label, prospective study of guanfacine in children with ADHD and tic disorders.
Boon‐yasidhi, V., Kim, Y. S., & Scahill, L. D. (2005) · PubMed · Cited by 26
Child and Adolescent Psychopharmacology Update
McVoy, M. K., & Findling, R. L. (2009) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.11.002 · Cited by 26
Maina, A., Arrotta, M., Cicogna, L., Donvito, V., Mischinelli, M., Todros, T., & Rivolo, S. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12757 · Cited by 26
López, R. G., Perea‐Milla, E., Garcia, C. R., Rivas‐Ruiz, F., Romero-González, J., Moreno, J. L. C., Felipe, V. F., Aguas, G. D. C., & Diaz, J. C. R. (2009) · Trials · doi:10.1186/1745-6215-10-16 · Cited by 26
Song, P., Jiang, L., Li, X., Hong, S., Li, S., & Hu, Y. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00032 · Cited by 25
Gilbert, D. L., & Buncher, C. R. (2005) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.17.3.324 · Cited by 25
Tourette syndrome research highlights 2015
Richards, C. A., & BLACK, K. J. (2016) · F1000Research · doi:10.12688/f1000research.8769.1 · Cited by 24
Cothros, N., Martino, D., McMorris, C. A., Stewart, D., Tehrani, A., & Pringsheim, T. M. (2019) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.459 · Cited by 24
Clinical Pharmacology of Nondopaminergic Drugs in Tourette Syndrome
Hartmann, A. (2013) · International review of neurobiology · doi:10.1016/b978-0-12-411546-0.00011-1 · Cited by 23
Literature Review: Beyond Methylphenidate
Wood, J. G., Crager, J. L., Delap, C. M., & Heiskell, K. D. (2007) · Journal of Attention Disorders · doi:10.1177/1087054707305968 · Cited by 23
Psychopharmacology of ADHD in pediatrics: current advances and issues
Greydanus, D. E. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s4075 · Cited by 23
Pringsheim, T. M. (2017) · Child Psychiatry & Human Development · doi:10.1007/s10578-017-0718-z · Cited by 22
Tourette’s disorder in children and adolescents
Greydanus, D. E., & Tullio, J. (2020) · Translational Pediatrics · doi:10.21037/tp.2019.09.11 · Cited by 23
Kociancic, T., Reed, M. D., & Findling, R. L. (2004) · Expert Opinion on Drug Safety · doi:10.1517/eods.3.2.93.27337 · Cited by 22
Anxiété et dépression chez les épileptiques en population générale au Bénin (Afrique de l’Ouest)
Nubukpo, P., Houinato, D. S., Preux, P., Avodé, G., & Clément, J. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95432-2 · Cited by 22
March, J. S., Chrisman, A. K., Breland‐Noble, A. M., Clouse, K., D'Alli, R., EGGER, H. L., Gammon, P., Gazzola, M., Lin, A., Mauro, C., et al. (2005) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.05.001 · Cited by 22
Gilles de la Tourette's Syndrome
Faridi, K., & Suchowersky, O. (2003) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100003267 · Cited by 21
A review of the growing evidence base for pediatric psychopharmacology
Pappadopulos, E. A., Guelzow, B. T., Wong, C., Ortega, M., & Jensen, P. S. (2004) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2004.04.007 · Cited by 21
Open-Label Amantadine in Children with Attention-Deficit/Hyperactivity Disorder
Donfrancesco, R., Calderoni, D., & Vitiello, B. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0128 · Cited by 20
Current therapies and therapeutic decision making for childhood‐onset movement disorders
Mohammad, S. S., Paget, S., & Dale, R. C. (2019) · Movement Disorders · doi:10.1002/mds.27661 · Cited by 20
Movement disorders in pregnancy
Smith, M., & Evatt, M. L. (2004) · Neurologic Clinics · doi:10.1016/j.ncl.2004.06.005 · Cited by 20
Stevens, J., George, R., Fusillo, S. J., Stern, T., & Wilens, T. (2010) · Journal of child and adolescent psychopharmacology · doi:10.1089/cap.2008.0128 · Cited by 16
Long-Term Consequences of Drugs on the Paediatric Cardiovascular System
Hausner, E. A., Fiszman, M. L., Hanig, J. P., Harlow, P., Zornberg, G. L., & Sobel, S. (2008) · Drug Safety · doi:10.2165/0002018-200831120-00005 · Cited by 20
Child Neurology: Diagnosis and treatment of Tourette syndrome
Hirschtritt, M. E., Dy-Hollins, M., Yang, K. G., & Scharf, J. M. (2016) · Neurology · doi:10.1212/wnl.0000000000002977 · Cited by 19
Tourette syndrome and other tic disorders of childhood
Nilles, C., Hartmann, A., Roze, E. F., Martino, D., & Pringsheim, T. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00002-8 · Cited by 19
Childress, A. C. (2012) · Advances in Therapy · doi:10.1007/s12325-012-0020-1 · Cited by 19
Tourette syndrome and tic disorders: overview and practical guide to diagnosis and treatment.
Swain, J. E., & Leckman, J. F. (2005) · PubMed Central · Cited by 19
The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder
Himpel, S., Banaschewski, T., Heise, C. A., & Rothenberger, A. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.2.311 · Cited by 19
Rothenberger, A., & Heinrich, H. (2022) · Biomedicines · doi:10.3390/biomedicines10112950 · Cited by 19
Changes and Challenges: Managing ADHD in a Fast-Paced World
Manos, M. J., Tom-Revzon, C., Bukstein, O. G., & Crismon, M. L. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.9-b.1 · Cited by 18
Budman, C. L., & Kurlan, R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-960-8_17 · Cited by 18
Banaschewski, T., Gerlach, M., Becker, K., Holtmann, M. H., Döpfner, M., & Romanos, M. (2016) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000433 · Cited by 19
Current pharmacotherapy for tic disorders
Cothros, N., Medina, A., & Pringsheim, T. M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721465 · Cited by 19
Himle, M. B., Chang, S. W., Woods, D. W., Bunaciu, L., Pearlman, A., Buzzella, B. A., & Piacentini, J. C. (2007) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-007-9066-4 · Cited by 18
assessment, I. A. M. H., (inattention, T. C. S. S. F. A. B. S. A. Q. R. T. M. S. D. O. A., impulsivity, the, A. H. A. A. W. S. S. C. I. T. S. Q. S. B. A. R. O. T. N. O. T. C. C. R. S. O. S. Q. C., symptoms of ADHD can also be included in clinic/office registration materials to be completed by parents before visits or in the waiting room before the evaluation. If a parent reports that the patient suffers from any symptoms of ADHD that induce impairment or if the patient scores in the clinical range for ADHD symptoms on a rating scale, & indicated., T. A. F. E. F. A. A. S. O. I. T. N. R. I. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.3.foc401 · Cited by 18
New treatments for tic disorders
Qasaymeh, M. M., & Mink, J. W. (2006) · Current Treatment Options in Neurology · doi:10.1007/s11940-006-0036-4 · Cited by 18
Attention deficit disorders: Are we barking up the wrong tree?
Cabral, P. (2006) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2006.02.004 · Cited by 18
Vesicular monoamine transport inhibitors: current uses and future directions
Rosenthal, L. S., Farag, M., Aziz, N. A., & Bang, J. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01072-4 · Cited by 17
Drug-Induced Movement Disorders: Emergencies and Management
Robottom, B., Shulman, L. M., & Weiner, W. J. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.09.007 · Cited by 17
Budman, C. L., Coffey, B. J., Dure, L. S., Gilbert, D. L., Juncos, J. J., Kaplan, E. L., King, R. A., Kurlan, R., Lowe, T. L., Mack, K. J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.005 · Cited by 17
Tic Suppression: The Medical Model
Wu, S. W., Harris, E., & Gilbert, D. L. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2010.0015 · Cited by 16
Sources of Disability in Tourette Syndrome: Children vs. Adults
Kompoliti, K. (2016) · Tremor and Other Hyperkinetic Movements · doi:10.5334/tohm.270 · Cited by 16
Baker, M., Huefner, J. C., Bellonci, C., Hilt, R. J., & Carlson, G. A. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0162 · Cited by 16
Developmental and Behavioral Disorders Grown Up: Tourette's Disorder
Zinner, S. H., & Coffey, B. J. (2009) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181bd7f3e · Cited by 16
Psychopharmacology Notes. Nonstimulant Medications for the Treatment of ADHD
Rains, A. L., & Scahill, L. D. (2006) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/j.1744-6171.2006.00044.x · Cited by 16
Attention deficit hyperactivity disorder and Tourette syndrome
Nass, R. D., & Bressman, S. (2002) · Neurology · doi:10.1212/wnl.58.4.513 · Cited by 16
Jaworowski, S., Benarroch, F., & Gross‐Tsur, V. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.365 · Cited by 15
Management of tics and Tourette's disorder: an update
Bestha, D. P., Jeevarakshagan, S., & Madaan, V. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.486402 · Cited by 15
Shahed, J. J. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.04.011 · Cited by 16
Viloxazine for the Treatment of Attention Deficit Hyperactivity Disorder
Robinson, C. L., Parker, K., Kataria, S., Downs, E., Supra, R., Kaye, A. D., Viswanath, O., & Urits, I. (2022) · Health Psychology Research · doi:10.52965/001c.38360 · Cited by 15
Syncope in children with Tourette's syndrome treated with guanfacine
King, A. A., Harris, P., Fritzell, J., & Kurlan, R. (2005) · Movement Disorders · doi:10.1002/mds.20738 · Cited by 14
Psychostimulants in Attention Deficit Hyperactivity Disorder
Connor, D. F. (2005) · Contemporary clinical neuroscience · doi:10.1385/1-59259-891-9:487 · Cited by 15
Tolerability Profile of Clonidine in the Treatment of Adults With Tourette Syndrome
Cavanna, A. E., Selvini, C., Termine, C., Balottin, U., & Eddy, C. M. (2012) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182741c39 · Cited by 14
Robertson, M. M. (2005) · Psychiatry · doi:10.1383/psyt.2005.4.8.92 · Cited by 14
APA Working Group on Psychoactive Medications for Children and Adolescents (2006) · PsycEXTRA Dataset · doi:10.1037/e539722009-001 · Cited by 14
Treatment of dystonia and tics
Bellows, S. T., & Jankovic, J. J. (2019) · Clinical Parkinsonism & Related Disorders · doi:10.1016/j.prdoa.2019.11.005 · Cited by 13
Rothenberger, A., & Banaschewski, T. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543807.022 · Cited by 13
Fortschritte in der Pharmakotherapie
Wilens, T. E., & Dittmann, R. (2003) · Springer eBooks · doi:10.1007/978-3-642-92473-6_7 · Cited by 13
Ashurova, M., Budman, C. L., & Coffey, B. J. (2021) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2020.10.006 · Cited by 12
An Update on the Diagnosis and Management of Tic Disorders
Desai, I., Kumar, N., & Goyal, V. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_724_23 · Cited by 12
Medical and Surgical Treatments of Tourette Syndrome
Shahed, J. J. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.01.006 · Cited by 12
A mini-review of non-parenteral clonidine preparations for paediatric sedation
Hanning, S. M., Orlu, M., Toni, I., Neubert, A. C., & Tuleu, C. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12662 · Cited by 12
Tourette’s syndrome in children
Swain, J. E., & Leckman, J. F. (2003) · Current Treatment Options in Neurology · doi:10.1007/s11940-003-0036-6 · Cited by 12
Meta-Assurance: No Tic Exacerbation Caused by Stimulants
Friedland, S., & Walkup, J. T. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.06.018 · Cited by 12
Treatment of Childhood Oppositional Defiant Disorder
Hood, B. S., Elrod, M. G., & DeWine, D. B. (2015) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-015-0015-7 · Cited by 11
Combination Therapy Patterns and Predictors of ADHD in Commercially Insured and Medicaid Populations
Molife, C., Bernauer, M. J., Farr, A. M., Haynes, V. S., & Kelsey, D. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2586 · Cited by 12
Child and Adolescent Psychiatric Disorders
Bostic, J. Q., & Prince, J. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50071-8 · Cited by 10
Treatment options for tic disorders
Rizzo, R., & Gulisano, M. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1698950 · Cited by 11
Jaffe, R. J., & Coffey, B. J. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.03.004 · Cited by 10
Farhat, L. C., Behling, E., Landeros‐Weisenberger, A., de Barros, P. M. F., Polanczyk, G. V., Cortese, S., & Bloch, M. H. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0049 · Cited by 10
Lyon, G. J., Shprecher, D., Coffey, B. J., & Kurlan, R. (2010) · Current Treatment Options in Neurology · doi:10.1007/s11940-010-0073-x · Cited by 10
Management of Pediatric Movement Disorders: Present and Future
Russ, J. B., Nallappan, A. M., & Robichaux‐Viehoever, A. (2018) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2018.02.004 · Cited by 10
Evidence-Based Pharmacotherapy for Pediatric Obsessive-Compulsive Disorder and Chronic Tic Disorders
Nadai, A. S. D., Storch, E. A., Mcguire, J. F., Lewin, A. B., & Murphy, T. K. (2011) · Journal of Central Nervous System Disease · doi:10.4137/jcnsd.s6616 · Cited by 10
Risk Factors for Comorbidity in ADHD and GTS: Looking Beyond a Single-Deficit Model
Murphy, T. L., & Muter, V. (2012) · Applied Neuropsychology Child · doi:10.1080/21622965.2012.703889 · Cited by 10
DRUG-INDUCED MOVEMENT DISORDERS
Horn, S. S. (2004) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000293573.31991.8a · Cited by 10
Roessner, V., Schoenefeld, K., Buse, J., Wanderer, S., & Rothenberger, A. (2012) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000176 · Cited by 10
Tics, tremors and other movement disorders in childhood
Blackburn, J., & Parnes, M. (2021) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2021.100983 · Cited by 10
Bloch, M. H. (2016) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12592 · Cited by 10
Pharmacotherapy for Tourette Syndrome
Jurgen, B., & Greenberg, E. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.08.008 · Cited by 9
An update on the pharmacological management of Tourette syndrome and emerging treatment paradigms
Lenka, A., & Jankovic, J. J. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2382463 · Cited by 9
Tourette Syndrome in Infancy and Early Childhood
Zinner, S. H. (2006) · Infants & Young Children · doi:10.1097/00001163-200610000-00007 · Cited by 9
Psychopharmacology of Tic Disorders in Children and Adolescents
Chadehumbe, M. A., Greydanus, D. E., Feucht, C. L., & Patel, D. R. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2010.10.004 · Cited by 9
Goldberg, J. (2002) · Evidence-Based Mental Health · doi:10.1136/ebmh.5.4.122 · Cited by 9
Martino, D., & Mink, J. W. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000436157.31662.af · Cited by 9
Pringsheim, T. M., Davenport, W. J., & Lang, A. E. (2003) · Current Opinion in Neurology · doi:10.1097/01.wco.0000084232.82329.47 · Cited by 9
Movement Disorders and Dopaminomimetic Stimulant Drugs
Munson, A. E., Sanchez‐Ramos, J., & Weiner, W. J. (2005) · Wiley eBooks · doi:10.1002/9780470753217.ch14 · Cited by 9
BLACK, K. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00385-3 · Cited by 9
Pharmacological Treatment of Tourette Disorder in Children
Can, A., Vermilion, J. A., Mink, J. W., & Morrison, P. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2023.0026 · Cited by 8
Roessner, V., & Rothenberger, A. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_26 · Cited by 8
Clonidine Extended-Release In Attention-Deficit Hyperactivity Disorder†
Croxtall, J. D. (2012) · CNS Drugs · doi:10.2165/11208310-000000000-00000 · Cited by 8
Treatment of psychiatric disturbances in common hyperkinetic movement disorders
Berardelli, I., Pasquini, M., Conte, A., Bologna, M., Berardelli, A., & Fabbrini, G. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1555475 · Cited by 8
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L. D., Erenberg, G., Berlin, C. M., Budman, C. L., Coffey, B. J., Jankovic, J. J., Kiessling, L. S., King, R. A., Kurlan, R., Lang, A. E., et al. (2006) · Neurotherapeutics · doi:10.1007/bf03207049 · Cited by 8
Controversies Surrounding Pediatric Psychopharmacology
Steinberg-Epstein, R., Book, T. M., & Wigal, S. B. (2011) · Advances in Pediatrics · doi:10.1016/j.yapd.2011.03.002 · Cited by 8
Tourette's Syndrome: A Multifactorial, Developmental Psychopathology
Spessot, A. L., & Peterson, B. S. (2015) · Wiley eBooks · doi:10.1002/9780470939406.ch11 · Cited by 8
Leckman, J. F., & Bloch, M. H. (2015) · Wiley eBooks · doi:10.1002/9781118381953.ch56 · Cited by 8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Storm, M. R. O., Ribeiro, J. P., Skoog, M., Groth, C., Edemann-Callesen, H., Schaug, J. P., Darling, P. J., Huus, C.-M. L., Zwi, M., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub4 · Cited by 10
Mohammadi, M. R., Badrfam, R., Khaleghi, A., Ahmadi, N., Hooshyari, Z., & Zandifar, A. (2021) · Child Psychiatry & Human Development · doi:10.1007/s10578-021-01186-7 · Cited by 7
Vilus, J. T., & Engelhard, C. (2025) · Pediatric Annals · doi:10.3928/19382359-20241007-07 · Cited by 7
Drug Class Review: Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder
McDonagh, M. S., & Peterson, K. (2011) · Cited by 7
Metadata
- Authors
- The Tourette’s Syndrome Study Group
- Corresponding author
- The Tourette’s Syndrome Study Group
- Venue
- Neurology
- Published
- 2002-02-26
- Volume
- 58
- Issue
- 4
- Pages
- 527-536
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2266471137
- Cited by
- 504
- References
- 40
- Citations by year
- 2026: 13 · 2025: 9 · 2024: 18 · 2023: 15 · 2022: 13 · 2021: 15 · 2020: 14 · 2019: 18 · 2018: 13 · 2017: 14 · 2016: 18 · 2015: 19 · 2014: 17 · 2013: 11 · 2012: 37
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns033654-04)
- National Institute of Neurological Disorders and Stroke (1R01NS33654)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Keywords
- attention deficit hyperactivity disorder, Tourette syndrome, tic disorders, methylphenidate, clonidine, combination therapy, impulsivity, hyperactivity, inattention, sedation
- MeSH terms
- Adolescent, Adrenergic alpha-Agonists, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Clonidine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Methylphenidate, Surveys and Questionnaires, Tic Disorders, Confidence Intervals, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review